Business Wire

New GSMA Study Highlights Key Trends Shaping the Future of Mobile

Del

The GSMA today published its second annual ‘Global Mobile Trends’ report, which provides exclusive data and analysis on the key trends shaping the future of the mobile ecosystem. Published at Mobile World Congress Americas being held in San Francisco this week, the 2017 edition of this flagship report series compiles data on mobile subscriber growth trends across both developed and emerging markets, plus insight on: device innovation beyond the smartphone; the evolution from 4G to 5G networks; industry financial performance and growth outlook; competition and convergence; and statistics for every region worldwide.

“Our latest Global Mobile Trends report provides a comprehensive view of the opportunities and challenges facing the mobile industry as we move into a new era of ubiquitous connectivity,” said Laxmi Akkaraju Chief Strategy Officer at the GSMA. “Built on best-in-class GSMA Intelligence data and produced by our in-house team of industry analysts, today’s report maps out how future networks and operator business models are evolving within a rapidly shifting industry landscape.”

Key takeaways from the 2017 edition of the Global Mobile Trends:

Connecting the next billion: Five billion people are now connected to mobile networks, representing two-thirds of the world’s population. However, growth is slowing; it took four years to move from 4 billion to 5 billion subscribers and connecting the next billion will take longer still. Meanwhile, smartphone and mobile broadband growth is driving mobile internet usage and engagement, and new form factors are emerging beyond the smartphone.

Rapid 4G growth: Industry excitement around 5G overlooks the fact that 4G still has plenty of headroom for future growth. 4G is forecast to account for two-thirds of global mobile connections by 2025 (up from around a quarter today), driven by increasing 4G adoption over this period in major emerging markets such as Brazil, India and Indonesia.

The pathway to 5G: Early 5G deployments will likely target high-bandwidth applications as an extension to 4G, notably 8K ultra-HD video and VR/AR apps, although the US will focus initially on using 5G as a last-mile technology for home broadband. South Korea and Japan are likely to be among the first 5G markets, showcasing the technology at the Olympics in 2018 and 2020, respectively. However, on a global basis, it’s expected that 5G networks will be rolled out at a slower rate than 4G and adoption is therefore also likely to be slower.

Transforming the network: A paradigm shift in network architecture is required to support the shift to 5G and Internet of Things, requiring the creation of decentralised networks that combine a number of network technologies (e.g. small cells, LPWA), using software-controlled network functions, and running over both licensed and unlicensed spectrum. Edge computing and network slicing will be needed to support major 5G applications.

Telecoms and media converging: Convergence is now occurring at an industry level, as evidenced by the recent M&A boom that is creating telco-media conglomerates that seek to unlock new opportunities by combining content offerings with core network services; examples include Verizon/AOL/Yahoo and the proposed tie-up between AT&T and Time Warner. However, investors have yet to price in a growth premium for converged telco-media plays, which continue to be valued significantly below major tech players. The quintet of Apple, Amazon, Facebook, Google and Netflix have collectively grown enterprise value 3.5x since 2010, with large telecoms operators remaining relatively flat over this period.

About the 2017 GSMA Global Mobile Trends

The report is based on data from GSMA Intelligence, the research arm of the GSMA, and selected third-party sources. The information is grouped into several chapters: consumer usage trends; subscriber and mobile internet growth in emerging markets; networks; financial performance (including revenue, EBITDA margin and capex trends); competitive landscape and cross-sector competition analysis; and statistics and commentaries on every regional mobile market worldwide.

The 2017 GSMA Global Mobile Trends report is available at: https://www.gsma.com/globalmobiletrends/ .

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

Contact information

GSMA
Media Contacts:
Clare Fenny
+44 20 7067 0749
CFenny@webershandwick.com
GSMA Press Office
pressoffice@gsma.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life19.11.2017 16:31Pressemelding

Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of Cancer Patients (FoCP), a non-profit organisation that supports cancer patients and their families. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005048/en/ During MENA's first Global Relay For Life walkathon - Source: Friends of Cancer Patients Taking place November 17-18 at the American University Sharjah, the inaugural UAE RFL saw more than 2,000 relayers participating in the overnight event, with a large number of individuals and institutions involved including 52 sch

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00Pressemelding

AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20Pressemelding

AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute

Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11Pressemelding

The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other

Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 16:20Pressemelding

Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to

Ncardia Announces Completion of €10.5M Investment Round17.11.2017 12:31Pressemelding

Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom